403 related articles for article (PubMed ID: 19450513)
1. Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein.
He L; Sabet A; Djedjos S; Miller R; Sun X; Hussain MA; Radovick S; Wondisford FE
Cell; 2009 May; 137(4):635-46. PubMed ID: 19450513
[TBL] [Abstract][Full Text] [Related]
2. Metformin and insulin meet in a most atypical way.
White MF
Cell Metab; 2009 Jun; 9(6):485-7. PubMed ID: 19490902
[TBL] [Abstract][Full Text] [Related]
3. Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5.
Caton PW; Nayuni NK; Kieswich J; Khan NQ; Yaqoob MM; Corder R
J Endocrinol; 2010 Apr; 205(1):97-106. PubMed ID: 20093281
[TBL] [Abstract][Full Text] [Related]
4. PPP1R3C mediates metformin-inhibited hepatic gluconeogenesis.
Ji X; Wang S; Tang H; Zhang Y; Zhou F; Zhang L; Zhu Q; Zhu K; Liu Q; Liu Y; Wang X; Zhou L
Metabolism; 2019 Sep; 98():62-75. PubMed ID: 31181215
[TBL] [Abstract][Full Text] [Related]
5. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.
Shaw RJ; Lamia KA; Vasquez D; Koo SH; Bardeesy N; Depinho RA; Montminy M; Cantley LC
Science; 2005 Dec; 310(5754):1642-6. PubMed ID: 16308421
[TBL] [Abstract][Full Text] [Related]
6. Potential biomarker of metformin action.
He L; Meng S; Germain-Lee EL; Radovick S; Wondisford FE
J Endocrinol; 2014 Jun; 221(3):363-9. PubMed ID: 24639469
[TBL] [Abstract][Full Text] [Related]
7. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
[TBL] [Abstract][Full Text] [Related]
8. Insulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein.
Zhou XY; Shibusawa N; Naik K; Porras D; Temple K; Ou H; Kaihara K; Roe MW; Brady MJ; Wondisford FE
Nat Med; 2004 Jun; 10(6):633-7. PubMed ID: 15146178
[TBL] [Abstract][Full Text] [Related]
9. Glucagon regulates gluconeogenesis through KAT2B- and WDR5-mediated epigenetic effects.
Ravnskjaer K; Hogan MF; Lackey D; Tora L; Dent SY; Olefsky J; Montminy M
J Clin Invest; 2013 Oct; 123(10):4318-28. PubMed ID: 24051374
[TBL] [Abstract][Full Text] [Related]
10. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
[TBL] [Abstract][Full Text] [Related]
11. Disrupting the CH1 domain structure in the acetyltransferases CBP and p300 results in lean mice with increased metabolic control.
Bedford DC; Kasper LH; Wang R; Chang Y; Green DR; Brindle PK
Cell Metab; 2011 Aug; 14(2):219-30. PubMed ID: 21803292
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional co-activator p300 maintains basal hepatic gluconeogenesis.
He L; Naik K; Meng S; Cao J; Sidhaye AR; Ma A; Radovick S; Wondisford FE
J Biol Chem; 2012 Sep; 287(38):32069-77. PubMed ID: 22815486
[TBL] [Abstract][Full Text] [Related]
13. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Insulin Resistance Following Chronic Activation of the CREB Coactivator CRTC2.
Hogan MF; Ravnskjaer K; Matsumura S; Huising MO; Hull RL; Kahn SE; Montminy M
J Biol Chem; 2015 Oct; 290(43):25997-6006. PubMed ID: 26342077
[TBL] [Abstract][Full Text] [Related]
15. Differential AMPK phosphorylation by glucagon and metformin regulates insulin signaling in human hepatic cells.
Aw DK; Sinha RA; Xie SY; Yen PM
Biochem Biophys Res Commun; 2014 May; 447(4):569-73. PubMed ID: 24735537
[TBL] [Abstract][Full Text] [Related]
16. Baicalin ameliorates hepatic insulin resistance and gluconeogenic activity through inhibition of p38 MAPK/PGC-1α pathway.
Fang P; Sun Y; Gu X; Shi M; Bo P; Zhang Z; Bu L
Phytomedicine; 2019 Nov; 64():153074. PubMed ID: 31473580
[TBL] [Abstract][Full Text] [Related]
17. Berberine Inhibits Gluconeogenesis in Skeletal Muscles and Adipose Tissues in Streptozotocin-induced Diabetic Rats via LKB1-AMPK-TORC2 Signaling Pathway.
Xu XH; Hu Q; Zhou LS; Xu LJ; Zou X; Lu FE; Yi P
Curr Med Sci; 2020 Jun; 40(3):530-538. PubMed ID: 32681256
[TBL] [Abstract][Full Text] [Related]
18. Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK).
Cao J; Meng S; Chang E; Beckwith-Fickas K; Xiong L; Cole RN; Radovick S; Wondisford FE; He L
J Biol Chem; 2014 Jul; 289(30):20435-46. PubMed ID: 24928508
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
[TBL] [Abstract][Full Text] [Related]
20. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange.
Liu Y; Dentin R; Chen D; Hedrick S; Ravnskjaer K; Schenk S; Milne J; Meyers DJ; Cole P; Yates J; Olefsky J; Guarente L; Montminy M
Nature; 2008 Nov; 456(7219):269-73. PubMed ID: 18849969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
